A clinical trial has found that a prescription form of the omega-3 fatty acid eicosapentaenoic acid (EPA) was associated with longer overall survival among patients undergoing surgery for colorectal ...

Agenus ( AGEN) reported that 72% of patients with locally advanced colon cancer had no detectable cancer remaining at surgery ...

A new study finds metastatic colorectal cancer's immune defenses may begin outside the cancer cell, challenging view held for ...

At the ESMO Congress 2026, Xencor Inc. XNCR shared updated results from the Phase 1 study of XmAb819 for advanced clear cell ...

IROCAS at ESMO 2026: mFOLFIRINOX vs mFOLFOX6 in High-Risk Stage III Colon Cancer / cancer, cancer care, Cancer research, ...

VASCEPA was associated with an increased risk (3% vs 2%) of atrial fibrillation or atrial flutter requiring hospitalization ...

But laparoscopic liver resection was associated with lower 30-day morbidity compared with open liver resection.

Incyte's INCB161734 KRAS G12D inhibitor posted 89% and 81% objective response rates in Phase I PDAC and CRC data at ESMO 2026 ...

Genmab A/S (Nasdaq: GMAB) today announced updated follow-up analyses from a Phase 2 trial evaluating petosemtamab, an ...

Curcumae Rhizoma herb pair synergistically enhances 5-fluorouracil against colorectal cancer by disrupting DNA repair and ...

Genmab presented clinical updates on petosemtamab, an investigational bispecific antibody, in two major solid tumor types at ...

A retrospective cohort of 163 patients treated at one Rwandan cancer center reported estimated median overall survival of ...